UNSPSC 85494322: Supplement pulmonary valve with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement pulmonary valve with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02UH4JZ

UNSPSC 85494322 Supplement pulmonary valve with synthetic substitute, percutaneous endoscopic approach is a Commodity code that does not align with recent state and local contract opportunities. The source contains six recent state and local solicitations tagged to this code, but none involve procurement of prosthetic heart valves or cardiovascular surgical devices. Instead, the opportunities span independent medical evaluation services for pension disability determinations, surgical benefit carve-out networks for employee health plans, occupational medical surveillance for transportation workers, emergency and specialty medical services for detained youth, pharmacy benefit management administration, and temporary health professional staffing. The mismatch indicates either a systematic miscoding of these opportunities at the state and local level or a fundamental misalignment between the UNSPSC code's nominal scope and its actual use in these jurisdictions' procurement systems.

The recent opportunities originate from diverse issuing bodies—the City of Phoenix Retirement Office (Arizona), the City of Long Beach (California), the Washington State Department of Transportation, Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and the County of Santa Clara Health System (California)—and span health care administration, occupational health compliance, and clinical staffing services rather than medical device supply. Without recent opportunities that actually involve procurement of prosthetic valves or cardiac device implantation supplies under this code, it presents no clear basis for business development pursuit in state and local markets.